{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:55:34Z","timestamp":1787972134542,"version":"build-2784847793"},"reference-count":118,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Immunology"],"published-print":{"date-parts":[[2025,5,4]]},"DOI":"10.1080\/1744666x.2025.2497845","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T11:19:12Z","timestamp":1745407152000},"page":"531-542","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Targeting the ubiquitin-proteasome pathway in systemic lupus erythematosus"],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3696-1228","authenticated-orcid":false,"given":"Chi Chiu","family":"Mok","sequence":"first","affiliation":[{"name":"Tuen Mun Hospital","place":["Hong Kong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211663"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728214.2014.894018"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2019.1551358"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1100359"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.10.003"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00035"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.649693"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102404"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0909927107"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2966"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2010.06.018"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202341"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2016.20"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202149675"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-083122-044829"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111646"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2022.100994"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/14789450.2022.2142564"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.04.023"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-010919-023603"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.206"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2016.00303"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2018.03.003"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1042\/EBC20160001"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.3273"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjq030"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0305-7372(03)00081-1"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.01.013"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111595"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b01226"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep34019"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/541984"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.01.037"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.7.4075"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-012-0938-0"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-009-0679-1"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1978"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206016"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1043680"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells11010009"},{"issue":"10","key":"e_1_3_4_43_1","first-page":"2045","article-title":"Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseases","volume":"29","author":"Egerer K","year":"2002","unstructured":"Egerer K, Kuckelkorn U, Rudolph PE, et al. Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseases. J Rheumatol. 2002;29(10):2045\u20132052.","journal-title":"J Rheumatol"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.4.1313"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14435"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568009614666140723113139"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.2174\/156800911794519752"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1075615"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.603278"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2017.08.005"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.06.010"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201303543"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.33333"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2012.04578.x"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.113964"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b01201"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.120.000307"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202249851"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1763"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2011.11.019"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1159\/000334955"},{"issue":"3","key":"e_1_3_4_62_1","first-page":"393","article-title":"Comparison of therapeutic efficacy between bortezomib and combination treatment of prednisolone and mycophenolate mofetil on nephritis in NZB\/WF1 mice","volume":"28","author":"Lee S-W","year":"2010","unstructured":"Lee S-W, Kim BS. Comparison of therapeutic efficacy between bortezomib and combination treatment of prednisolone and mycophenolate mofetil on nephritis in NZB\/WF1 mice. Clin Exp Rheumatol. 2010;28(3):393\u2013396.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135081"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1397-7"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket284"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203316686703"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201847492"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203319896018"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.756941"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-023-06559-y"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2018.1432331"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-eular.2700"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203317691371"},{"key":"e_1_3_4_74_1","unstructured":"Zetomipzomib (KZR-616) a first-in-Class selective Immunoproteasome inhibitor demonstrated improvements in SLE\/LN disease measures and biomarkers in patients with highly active SLE or nephrotic range proteinuria in the open-label phase 1b\/2 MISSION study [internet]. ACR meeting abstracts. [cited 2024 Dec 29]. Available from: https:\/\/acrabstracts.org\/abstract\/zetomipzomib-kzr-616-a-first-in-class-selective-immunoproteasome-inhibitor-demonstrated-improvements-in-sle-ln-disease-measures-and-biomarkers-in-patients-with-highly-active-sle-or-nephrotic-range"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1080\/14789450.2022.2142564"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.66"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12708"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2011.03.006"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2012.02.023"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2012.277"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212916"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2020-000445"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b01921"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2022-222212"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes227"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12804"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12565.x"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000001160"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead116"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2021-9-8"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4111"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.11.007"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1159\/000508672"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.3350"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2021-000581"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2106535"},{"issue":"24","key":"e_1_3_4_97_1","first-page":"03044","article-title":"Effect of iberdomide on cutaneous manifestations in systemic lupus erythematosus: a randomized phase 2 clinical trial","volume":"0190","author":"Werth VP","year":"2024","unstructured":"Werth VP, Merrill JT, Furie R, et al. Effect of iberdomide on cutaneous manifestations in systemic lupus erythematosus: a randomized phase 2 clinical trial. J Am Acad Dermatol. 2024;S0190\u20139622(24):03044\u20135.","journal-title":"J Am Acad Dermatol"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01856-x"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12463"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI149095"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38742"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27233"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.34359"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38037"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220920"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2410965"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2023.2192927"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.2478\/rir-2020-0005"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(19)30076-1"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912196"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00466-6"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2023325"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02479-1"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11111721"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2308917"},{"key":"e_1_3_4_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)02381-X"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04221-0"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2407150"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.03.008"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.2174\/1573397114666180406100857"}],"container-title":["Expert Review of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1744666X.2025.2497845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T03:57:37Z","timestamp":1758513457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1744666X.2025.2497845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":118,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,4]]}},"alternative-id":["10.1080\/1744666X.2025.2497845"],"URL":"https:\/\/doi.org\/10.1080\/1744666x.2025.2497845","relation":{},"ISSN":["1744-666X","1744-8409"],"issn-type":[{"value":"1744-666X","type":"print"},{"value":"1744-8409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-01-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}